Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001085146-25-004272·Cowen Financial Products LLC
Schedule 13G ownership disclosure
UROGEN PHARMA LTD
Ordinary Shares, par value NIS 0.01 per share · CUSIP: M96088105
Event date: 2025-06-30
- Filing-level shares
- 3,190,510
- Percent of class
- 6.9%
- Cowen Financial Products LLC
Shares: 3,190,510 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-004272
- Form type
- SCHEDULE 13G/A
- Filer
- Cowen Financial Products LLC
- CIK
- CIK 1771015
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership